Chondroitin sulfate functionalized mesostructured silica nanoparticles as biocompatible carriers for drug delivery

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5235-5247

  Xi, Juqun ^a   Qin, Jin ^a   Fan, Lei ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Chondroitin sulfate; Drug delivery; Mesoporous silica nanoparticle; pH sensitive

Indexed keywords

CHONDROITIN SULFATE; DOXORUBICIN; NANOPARTICLE; SILICA NANOPARTICLE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOCOMPATIBILITY; CELL ASSAY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; COVALENT BOND; CROSS LINKING; DRUG COATING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; PARTICLE SIZE; PH MEASUREMENT; TRANSMISSION ELECTRON MICROSCOPY;

BIOCOMPATIBLE MATERIALS; CHONDROITIN SULFATES; CRYSTALLIZATION; DIFFUSION; MATERIALS TESTING; NANOCAPSULES; PARTICLE SIZE; SILICON DIOXIDE;

EID: 84870349310     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S34128     Document Type: Article

References (36)

1. Sultana Y, Maurya DP, Iqbal Z, etal. Nanotechnology in ocular delivery: current and future directions. Drugs Today (Barc). 2011;47(6):441-455.
2. Talekar M, Kendall J, Denny W, etal. Targeting of nanoparticles in cancer: drug delivery and diagnostics. Anticancer Drugs. 2011;22(10):949-962.
3. Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine. 2012;8(2):147-166.
4. Hosseinkhani H, Tabata Y. Self assembly of DNA nanoparticles with polycations for the delivery of genetic materials into cells. J Nanosci Nanotechnol. 2006;6(8):2320-2328.
5. Jiang W, Kim BY, Rutka JT, Chan WC. Advances and challenges of nanotechnology-based drug delivery systems. Expert Opin Drug Deliv. 2007;4(6):621-633.
6. Hosseinkhani H, Hosseinkhani M, Gabrielson NP, etal. DNA nanoparticles encapsulated in 3D tissue-engineered scaffolds enhance osteogenic differentiation of mesenchymal stem cells. J Biomed Mater Res A. 2008;85(1):47-60.
7. Yang PP, Gai SL, Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev. 2012;41(9):3679-3698.
8. Faiza S, Fabiola P, Annemarie HM, etal. Mesoporous silica nanoparticles as a compound delivery system in zebrafish embryos. Int J Nanomedicine. 2012;7:1875-1890.
9. Singh N, Karambelkar A, Gu L, etal. Bioresponsive mesoporous silica nanoparticles for triggered drug release. J Am Chem Soc. 2011; 133(49):19582-19585.
10. Tsai CH, Vivero-Escoto JL, Slowing II, etal. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles. Biomaterials. 2011;32(26): 6234-6244.
11. Sarparanta M, Bimbo LM, Rytkönen J, etal. Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution, Mol Pharmaceutics. 2012;9(3):654-663.
12. Pablo B, Ibane A, Yolanda F, etal. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation. J Control Release. 2011;156(2):246-257.
13. Liu YT, Mi Y, Zhao J, etal. Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents. Int J Pharm. 2011;421(2):370-378.
14. Slowing II, Vivero-Escoto JL, Wu CW, etal. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev. 2008;60(11):1278-1288.
15. He Q, Zhang Z, Gao Y, etal. Intracellular localization and cytotoxicity of spherical mesoporous silica nano-and microparticles. Small. 2009;5(23):2722-2729.
16. He QJ, Zhang ZW, Gao F, etal. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: Effects of particle size and PEGylation. Small. 2011;7(2):271-280.
17. Popat A, Liu J, Lu GQ, Qiao SZ. pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles. J Mater Chem. 2012;22(22):11173-11178.
18. Chen F, Zhu YC. Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: Sensitive response to the narrow pH range. Micropor Mesopor Mater. 2012;150(1):83-89.
19. He QJ, Zhang JM, Shi JL, Zhu ZY, etal. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials. 2010;31(6):1085-1092.
20. Yuan L, Tang QQ, Yang D, etal. Preparation of pH-Responsive meso-porous silica nanoparticles and their application in controlled drug delivery. J Phys Chem C. 2011;115(20):9926-9932.
21. Liu R, Liao PH, Liu JK, Feng PY. Responsive polymer-coated mesoporous silica as a pH-sensitive nanocarrier for controlled release. Langmuir. 2011;27(6):3095-3099.
22. Zhu YF, Meng WJ, Gao H, etal. Hollow mesoporous silica/poly(L-lysine) particles for co-delivery of drug and gene with enzyme-triggered release property. J Phys Chem C. 2011;115(28):13630-13636.
23. Fu Q, Rao GVR, Ista LK, etal. Control of molecular transport through stimuli-responsive ordered mesoporous materials. Adv Mater. 2003;15(15):1262-1266.
24. Tang J, Slowing II, Huang YL, etal. Poly(lactic acid)-coated mesoporous silica nanosphere for controlled release of venlafaxine. J Colloid Interface Sci. 2011;360(2):488-496.
25. Mikami KT, Uyama T, Mizuguchi S, Nomura K, Kitagawa H. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struc Biol. 2003;13(5):612-620.
26. Ketschek AR, Haas C, Gallo G, Fischer I. The roles of neuronal and glial precursors in overcoming chondroitin sulfate proteoglycan inhibition. Exp Neurol. 2012;35(2):627-637.
27. Bagari R, Bansal D, Gulbake A, etal. Chondroitin sulfate functionalized liposomes for solid tumor targeting. J Drug Target. 2011;19(4):251-257.
28. Lai JY, Li YT, Cho CH, etal. Nanoscale modification of porous gelatin scaffolds with chondroitin sulfate for corneal stromal tissue engineering. Int J Nanomedicine. 2012;7:1101-1114.
29. Li FY, Na K. Self-assembled chlorin e6 conjugated chondroitin sulfate nanodrug for photodynamic therapy. Biomacromolecules. 2011;12(5):1724-1730.
30. Huang SJ, Sun SL, Feng TH, etal. Folate-mediated chondroitin sulfate-pluronic 127 nanogels as a drug carrier. Eur J Pharm Sci. 2009;38(1): 64-73.
31. Xi JQ, Zhou L, Fei YH. Preparation of chondroitin sulfate nanocapsules for use as carries by the interfacial polymerization method. Int J Biol Macromol. 2012;50(1):157-163.
32. Xi JQ, Zhou L, Dai Hua. Drug-loaded chondroitin sulfate-based nanogels: Preparation and characterization. Colloid Surface B. 2012;100(12):107-115.
33. Zhu A, Pan Y, Dai S, etal. Preparation of N-maleoylchitosan nanocapsules for loading and sustained release of felodipine. Biomacromolecules. 2009;10(7):1997-2002.
34. Wang SC, Chen BH, Wang LF, Chen JS. Characterization of chondroitin sulfate and its interpenetrating polymer network hydrogels for sustained-drug release. Int J Pharm. 2007;329(1-2):103-109.
35. Gao Q, Xu Y, Wu D, Sun Y, Li X. pH-responsive drug release from polymer-coated mesoporous silica spheres. J Phys Chem C. 2009;113(29):12753-12758.
36. Shi X, Wang Y, Varshney RR, Ren L, Zhang F, Wang DA. In-vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite. Biomaterials. 2009;30(23-24):3996-4005.